Publications 2021

Alavi DH, Henriksen HB, Lauritzen PM, Kvaerner AS, Sakinis T, Langleite TM, Henriksen C, Bohn SK, Paur I, Wiedswang G, Smeland S, Blomhoff R (2021)
Quantification of adipose tissues by Dual-Energy X-Ray Absorptiometry and Computed Tomography in colorectal cancer patients
Clin. Nutr. ESPEN, 43, 360-368
DOI 10.1016/j.clnesp.2021.03.022

Helland T, Naume B, Hustad S, Bifulco E, Kvaloy JT, Saetersdal AB, Synnestvedt M, Lende TH, Gilje B, Mjaaland I, Weyde K, Blix ES, Wiedswang G, Borgen E, Hertz DL, Janssen EAM, Mellgren G, Soiland H (2021)
Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen
Mol. Oncol., 15 (4), 957-967
DOI 10.1002/1878-0261.12865

Hugenschmidt H, Labori KJ, Borgen E, Brunborg C, Schirmer CB, Seeberg LT, Naume B, Wiedswang G (2021)
Preoperative CTC-Detection by CellSearch(R) Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
Cancers, 13 (3), 485
DOI 10.3390/cancers13030485

Publications 2020

Barebring L, Kvaerner AS, Skotnes M, Henriksen HB, Skjetne AJ, Henriksen C, Raeder H, Paur I, Bohn SK, Wiedswang G, Smeland S, Blomhoff R (2020)
Use of bioelectrical impedance analysis to monitor changes in fat-free mass during recovery from colorectal cancere-a validation study
Clin. Nutr. ESPEN, 40, 201-207
DOI 10.1016/j.clnesp.2020.09.021

Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Schirmer CB, Renolen A, Borgen E, Naume B, Wiedswang G (2020)
Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information
BMC Cancer, 20 (1), 1107
DOI 10.1186/s12885-020-07510-z

Hugenschmidt H, Labori KJ, Brunborg C, Verbeke CS, Seeberg LT, Schirmer CB, Renolen A, Borgen EF, Naume B, Wiedswang G (2020)
Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma
Ann. Surg., 271 (3), 549-558
DOI 10.1097/SLA.0000000000003035

Publications 2018

Kvaerner AS, Minaguchi J, El Yamani N, Henriksen C, Raeder H, Paur I, Henriksen HB, Wiedswang G, Smeland S, Blomhoff R, Collins AR, Bohn SK (2018)
DNA damage in blood cells in relation to chemotherapy and nutritional status in colorectal cancer patients-A pilot study
DNA Repair, 63, 16-24
DOI 10.1016/j.dnarep.2018.01.005

Publications 2017

Chellappa S, Hugenschmidt H, Hagness M, Subramani S, Melum E, Line PD, Labori KJ, Wiedswang G, Tasken K, Aandahl EM (2017)
CD8 (+) T Cells That Coexpress ROR gamma t and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
J. Immunol., 198 (4), 1729-1739
DOI 10.4049/jimmunol.1600061

Seeberg LT, Brunborg C, Waage A, Hugenschmidt H, Renolen A, Stav I, Bjornbeth BA, Borgen E, Naume B, Brudvik KW, Wiedswang G (2017)
Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases
Ann. Surg. Oncol., 24 (8), 2113-2121
DOI 10.1245/s10434-017-5818-2

Publications 2016

Chellappa S, Hugenschmidt H, Hagness M, Line PD, Labori KJ, Wiedswang G, Tasken K, Aandahl EM (2016)
Regulatory T cells that co-express RORt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer
OncoImmunology, 5 (4), e1102828
DOI 10.1080/2162402X.2015.1102828

Publications 2015

Brudvik KW, Seeberg LT, Hugenschmidt H, Renolen A, Schirmer CB, Brunborg C, Bjornbeth BA, Borgen E, Naume B, Waage A, Wiedswang G (2015)
Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases
Ann. Surg. Oncol., 22 (12), 4029-4037
DOI 10.1245/s10434-015-4482-7

Seeberg LT, Waage A, Brunborg C, Hugenschmidt H, Renolen A, Stav I, Bjornbeth BA, Brudvik KW, Borgen EF, Naume B, Wiedswang G (2015)
Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival
Ann. Surg., 261 (1), 164-171
DOI 10.1097/SLA.0000000000000580

Publications 2014

Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, Saetersdal AB, Rypdal MC, Schirmer CB, Wist EA, Borgen E (2014)
Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer
J. Clin. Oncol., 32 (34), 3848-U245
DOI 10.1200/JCO.2014.56.9327

Publications 2012

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
Histopathology, 61 (3), 350-364
DOI 10.1111/j.1365-2559.2012.04223.x

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
Histol. Histopath., 27 (10), 1315-1325

Synnestvedt M, Borgen E, Wist E, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Schirmer C, Nesland JM, Naume B (2012)
Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study
BMC Cancer, 12, 616
DOI 10.1186/1471-2407-12-616

Publications 2011

Janni W, Vogl FD, Wiedswang G, Synnestvedt M, Fehm T, Juckstock J, Borgen E, Rack B, Braun S, Sommer H, Solomayer E, Pantel K, Nesland J, Friese K, Naume B (2011)
Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse-A European Pooled Analysis
Clin. Cancer Res., 17 (9), 2967-2976
DOI 10.1158/1078-0432.CCR-10-2515

Publications 2010

Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
Mol. Oncol., 4 (2), 169
DOI 10.1016/j.molonc.2010.01.003

Van Belle V, Van Calster B, Brouckaert O, Bempt IV, Pintens S, Harvey V, Murray P, Naume B, Wiedswang G, Paridaens R, Moerman P, Amant F, Leunen K, Smeets A, Drijkoningen M, Wildiers H, Christiaens MR, Vergote I, Van Huffel S, Neven P (2010)
Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer Diagnosis
J. Clin. Oncol., 28 (27), 4129-4134
DOI 10.1200/JCO.2009.26.4200

Publications 2009

Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
Breast carcinoma vascularity: A comparison of manual microvessel count and Chalkley count
Histol. Histopath., 24 (8), 1049-1059

Publications 2008

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM (2008)
Vascularization in primary breast carcinomas: Its prognostic significance and relationship with tumor cell dissemination
Clin. Cancer Res., 14 (8), 2341-2350
DOI 10.1158/1078-0432.CCR-07-4214

Publications 2007

Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2007)
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
Mol. Oncol., 1 (2), 160-171
DOI 10.1016/j.molonc.2007.03.004

Wiedswang G (2007)
Kap 14: Mikrometastaser ved brystkreft
In Brystkreft - diagnostikk og behandling Novartisserien , Faghefte nr 12, Novartis
PublikaID 66

Wiedswang G, Naume B (2007)
Can detection of circulating tumor cells in peripheral blood provide prognostic data in breast cancer? Commentary
Nat. Clin. Pract. Oncol., 4 (3), 154-155
DOI 10.1038/ncponc0742

Publications 2006

Wiedswang G, Borgen E, Schirmer C, Karesen R, Kvalheim G, Nesland JM, Naume B (2006)
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer
Int. J. Cancer, 118 (8), 2013-2019
DOI 10.1002/ijc.21576

Publications 2005

Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GYC, Bliss J, Vincent-Salomon A, Pantel K (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
N. Engl. J. Med., 353 (8), 793-802
DOI 10.1056/NEJMoa050434

Publications 2004

Naume B, Wiedswang G, Borgen E, Kvalheim G, Karesen R, Quist H, Janbu J, Harbitz TB, Nesland JM (2004)
The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells
In Clinical cancer research, AACR Publications Department, Philadelphia, PA, 10(2004)9, S. 3091-7
BIBSYS 05181322x

Naume B, Wiedswang G, Borgen E, Kvalheim G, Karesen R, Qvist H, Janbu J, Harbitz T, Nesland JM (2004)
The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: Evaluation of morphological categories and the number of clinically significant cells
Clin. Cancer Res., 10 (9), 3091-3097
DOI 10.1158/1078-0432.CCR-03-0373

Wiedswang G (2004)
The clinical relevance of detecting isolated tumour cellsin bone marrow and lymph nodes in breast cancer
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 226, 1 b. (flere pag.)
BIBSYS 042300541, ISBN 82-8080-131-6

Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B (2004)
Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome
Clin. Cancer Res., 10 (16), 5342-5348
DOI 10.1158/1078-0432.CCR-04-0245

Publications 2003

Sauer T, Wiedswang G, Boudjema G, Christensen H, Karesen R (2003)
Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?
APMIS, 111 (3), 444-450
DOI 10.1034/j.1600-0463.2003.t01-1-1110210.x

Wiedswang G, Borgen E, Karesen R, Kvalheim G, Nesland JM, Schlichting HQE, Sauer T, Janbu J, Harbitz T, Naume B (2003)
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer
J. Clin. Oncol., 21 (18), 3469-3478
DOI 10.1200/JCO.2003.02.009

Wiedswang G, Borgen E, Karesen R, Naume B (2003)
Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed
Cytotherapy, 5 (1), 40-45
DOI 10.1080/14653240310000065

Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist HL, Schlichting E, Sauer T, Janbu J, Harbitz TB, Naume B (2003)
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer
In Journal of clinical oncology, The Society, Alexandria VA, 21(2003)18, s.3469-78
BIBSYS 041728920

Publications 2001

Wiedswang G, Naess AB, Naume B, Karesen R (2001)
Micrometastasis to axillary lymph nodes and bone marrow in breast cancer patients
Breast, 10 (3), 237-242
DOI 10.1054/brst.2000.0245

Publications 1993

OPSJON SL, WATHEN NC, TINGULSTAD S, WIEDSWANG G, SUNDAN A, WAAGE A, AUSTGULEN R (1993)
TUMOR-NECROSIS-FACTOR, INTERLEUKIN-1, AND INTERLEUKIN-6 IN NORMAL HUMAN-PREGNANCY
Am. J. Obstet. Gynecol., 169 (2), 397-404
DOI 10.1016/0002-9378(93)90096-2

Publications 1989

WIEDSWANG G, MOEN MH (1989)
NONPUERPERAL INVERSION OF THE UTERUS
Acta Obstet. Gynecol. Scand., 68 (6), 559-560
DOI 10.1111/j.1600-0412.1989.tb07839.x